Neurocrine Bio. (NBIX) PT Raised to $200 at Canaccord

April 6, 2026 2:41 PM EDT Send to a Friend

Canaccord analyst Sumant Kulkarni raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Neurocrine Bio. (NBIX) PT Raised to $200 at Canaccord

Member Login

Free News Feed